Deraphar

Deraphar has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €270,143 and a net result of -€88,165. Equity is growing by about 4.1% per year across the filed financial years. Its solvency ranks better than 48% of 12,502 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).